Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 44

Results: 8

Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3880, doi. 10.1038/onc.2009.242

By:

Ashley, N;
Poulton, J

Publication type:

Article

Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3937, doi. 10.1038/onc.2009.245

By:

Li, X-F;
Yan, P-J;
Shao, Z-M

Publication type:

Article

p53 responsive elements in human retrotransposons.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3857, doi. 10.1038/onc.2009.246

By:

Harris, C R;
DeWan, A;
Zupnick, A;
Normart, R;
Gabriel, A;
Prives, C;
Levine, A J;
Hoh, J

Publication type:

Article

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3926, doi. 10.1038/onc.2009.241

By:

Leivonen, S-K;
Mäkelä, R;
Östling, P;
Kohonen, P;
Haapa-Paananen, S;
Kleivi, K;
Enerly, E;
Aakula, A;
Hellström, K;
Sahlberg, N;
Kristensen, V N;
Børresen-Dale, A-L;
Saviranta, P;
Perälä, M;
Kallioniemi, O

Publication type:

Article

Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D<sub>3</sub>.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3892, doi. 10.1038/onc.2009.247

By:

Kaler, P;
Augenlicht, L;
Klampfer, L

Publication type:

Article

The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3915, doi. 10.1038/onc.2009.248

By:

Baum, N;
Schiene-Fischer, C;
Frost, M;
Schumann, M;
Sabapathy, K;
Ohlenschläger, O;
Grosse, F;
Schlott, B

Publication type:

Article

The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3903, doi. 10.1038/onc.2009.249

By:

Shah, K M;
Stewart, S E;
Wei, W;
Woodman, C B J;
O'Neil, J D;
Dawson, C W;
Young, L S

Publication type:

Article

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.

Published in:

Oncogene, 2009, v. 28, n. 44, p. 3866, doi. 10.1038/onc.2009.257

By:

Seckinger, A;
Meißner, T;
Moreaux, J;
Goldschmidt, H;
Fuhler, G M;
Benner, A;
Hundemer, M;
Rème, T;
Shaughnessy, J D;
Barlogie, B;
Bertsch, U;
Hillengass, J;
Ho, A D;
Pantesco, V;
Jauch, A;
De Vos, J;
Rossi, J F;
Möhler, T;
Klein, B;
Hose, D

Publication type:

Article